Developer docs
API playgroundTry for free, no card

Search company profiles

International Brands

Full company profile

uuid00241rn

Namestring
International Brands
Legal namestring
International Brands (Private) Limited
Websiteurl
iblgrp.com
Company typeenum
Private
Founded yearint
1991
Descriptiontext

International Brands (Private) Limited-IBL is a Pakistani diversified business house headquartered in Karachi, operating through a portfolio of subsidiary companies spanning pharmaceutical manufacturing and distribution, consumer goods distribution, enterprise IT systems integration, home furnishings retail, and LED/solar energy solutions. The group traces its origins to 1887 as a distribution house for W.D. & H.O. Wills cigarettes across the Indian subcontinent, was reorganized as UDL – United Distributors after the 1947 partition, and was formally constituted as IBL in 1991 to extend distribution reach and diversify into manufacturing and marketing. Its core pharmaceutical franchise is built around The Searle Company Limited (acquired in 1993 from G.D. Searle), one of the largest pharma companies in Pakistan by therapeutic breadth, and IBL Operations, which serves as sole representative for sales and distribution. The group's revenue model is multi-stream: transaction-fee pharmaceutical distribution (Searle), consumer goods distribution and brand-building services (United Brands Limited, publicly listed on Pakistan Stock Exchange), licensing/royalty arrangements for healthcare nutrition and medical disposables (Mead Johnson, Nestle Health Science, Terumo, Meditech, Mepaco), professional services for enterprise IT integration (IBL Unisys with Cisco, Dell, EMC, Microsoft, Unisys, VMware), hardware/retail through Habitt, and LED lighting and solar renewable solutions via Future Technologies.

The company serves enterprise and institutional customers across Pakistan, including pharmaceutical manufacturers, multinational consumer brands, banks, telecom operators, government agencies, energy-sector enterprises, and educational institutions, with downstream reach to Pakistani consumers through Habitt retail and Searle products. Its go-to-market relies on field sales teams, exclusive distribution rights, enterprise IT systems integration, and licensing/royalty structures financed through capital deployed in acquisitions and subsidiary build-outs. The 1,001–5,000 employee base is distributed across the registered offices of IBL Operations and United Brands (NIC Building, Abbasi Shaheed Road, Karachi) and the main headquarters at One IBL Center, Tipu Sultan Road. Limited public transparency exists around revenue, pricing, and ownership beyond the founding Abdulla family, and the group has faced regulatory scrutiny from the Competition Commission of Pakistan over an anti-competitive non-compete agreement (Rs 40 million cumulative penalty upheld by the Competition Appellate Tribunal).

Short descriptiontext

International Brands (Private) Limited-IBL is a Pakistani diversified conglomerate operating subsidiaries across pharmaceutical manufacturing and distribution (Searle, IBL Operations), healthcare nutrition licensing (Mead Johnson, Nestle Health Science), consumer goods distribution (United Brands), enterprise IT integration (IBL Unisys), home furnishings retail (Habitt), and LED/solar solutions (Future Technologies), serving enterprise and consumer customers across Pakistan.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersKarachi, Pakistan
HQ citystring
Karachi
HQ countrystring
Pakistan
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, consumer goods trading, enterprise IT integration, home furnishings retail, LED lighting solutions
NAICS code1 code
  • Management of Companies and Enterprises551
SIC code2 codes
  • Wholesale-Computers & Peripheral Equipment & Software5045
  • Wholesale-Professional & Commercial Equipment & Supplies5040
Product category
Diversified Business Conglomerate
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model6 records
1Pharmaceutical Distribution and Marketing
TypeTransaction Fee
Description

IBL Operations serves as sole representative of The Searle Company Limited, managing marketing, promotion, and distribution of pharmaceutical products through a network of refined experts.

iblgrp.com
2Consumer Goods Trading and Distribution
TypeTransaction Fee
Description

United Brands Limited trades and distributes consumer goods and allied products, providing brand building services including brand communications, activations, channel development, trade marketing, modern trade activations, merchandising, in-store promotions, pricing and market intelligence.

iblgrp.com
3Healthcare Products Marketing
TypeLicensing Royalties
Description

IBL Healthcare markets products under licensing agreements with international companies including Mead Johnson Nutrition, Nestle Health Science, Terumo, Meditech and Mepaco in infant formula, adult nutrition and medical disposable products.

iblgrp.com
4Technology Solutions Integration
TypeProfessional Services
Description

IBL Unisys provides technology implementation and support services as a system integrator for enterprise clients in banking, telecom, government, and energy sectors.

iblgrp.com
5Retail and Home Furnishings
TypeHardware Sales
Description

Habitt operates as a one-stop home store solution for Pakistani consumers, offering superior quality products and value for money.

iblgrp.com
6LED Lighting and Renewable Energy Solutions
TypeHardware Sales
Description

Future Technologies markets LED lighting solutions, Building Management Systems and Solar Renewables with comprehensive product warranties and on-site support.

iblgrp.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 7 records shown
1Searle
Description

Pharmaceutical company manufacturing and marketing pharmaceutical products including allergy/cough/cold, analgesics, antibiotics, cardiovascular, gastrointestinal, and other therapeutic categories.

iblgrp.com
+6 more records
Core offering1 text field

International Brands (Private) Limited is a diversified business house that manufactures, markets, distributes, and sells pharmaceutical, consumer goods, healthcare nutrition, enterprise IT, home furnishings, and LED/renewable energy products through multiple subsidiaries operating primarily in Pakistan. Its core operations include pharmaceutical manufacturing and exclusive distribution (Searle, IBL Operations), consumer goods trading for international brands (United Brands Limited), enterprise IT system integration with global vendors (IBL Unisys), home retail (Habitt), and renewable energy solutions (Future Technologies).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Serving over 200,000 students through The Citizen Foundation
+1 more record
Product overview1 text field

International Brands (Private) Limited (IBL) is a diversified business house operating as a platform of multiple subsidiary and affiliated companies. The portfolio includes: SEARLE (pharmaceutical manufacturing and marketing), IBL Operations (pharmaceutical and nutritional product distribution), IBL HealthCare (healthcare nutritional products and medical disposables marketing), United Brands Limited (consumer goods trading and distribution), IBL Unisys (technology system integration), Habitt (home furnishings retail), and Future Technologies (LED lighting and renewable energy solutions). These entities operate independently under the IBL Group umbrella, providing distribution, manufacturing, marketing, retail, and technology services primarily in Pakistan.

Product and service2 records
1The Searle Company Limited (Searle)
CategoryPharmaceutical Manufacturing and Marketing
Description

Pharmaceutical company engaged in manufacturing and marketing of pharmaceutical products across therapeutic categories including allergy/cough/cold, analgesics, antibiotics, cardiovascular, gastrointestinal, neurological, and nutritional products in Pakistan.

2IBL Operations (Private) Limited
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1The Searle Company Limited
Strategic tierCoreTypeStrategic or Co-development Partner
Description

IBL Operations is a subsidiary and sole representative of The Searle Company Limited, handling all aspects from product launch, development and sales growth to marketing, distribution and awareness creation of pharmaceutical products.

iblgrp.com
Strategic tierCoreTypeTechnology or Integration
Description

IBL Unisys operates as a technology system integrator in partnership with Cisco for enterprise IT solutions.

Strategic tierCoreTypeTechnology or Integration
Description

IBL Unisys provides enterprise IT solutions in partnership with Dell.

Strategic tierCoreTypeTechnology or Integration
Description

IBL Unisys provides enterprise IT solutions in partnership with EMC.

Strategic tierCoreTypeTechnology or Integration
Description

IBL Unisys provides enterprise IT solutions in partnership with Microsoft.

Strategic tierCoreTypeTechnology or Integration
Description

IBL Unisys provides enterprise IT solutions in partnership with VMware.

Strategic tierCoreTypeTechnology or Integration
Description

IBL Unisys operates as a technology system integrator in partnership with Unisys for enterprise IT solutions.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Pakistan-founded IT services and system integrator with enterprise and digital transformation offerings, comparable to IBL Unisys's enterprise IT integration business.

TypeDirect peer
Description

Pakistani family-owned conglomerate active in textiles, cement, banking, and consumer goods; comparable diversification pattern and domestic-market orientation.

TypeDirect peer
Description

Pakistani diversified conglomerate with operations across fertilizers, foods, energy, and trading; comparable to IBL as a holding-company structure with multiple listed subsidiaries serving Pakistan's domestic market.

TypeBroad incumbent
Description

Listed Pakistani pharmaceutical manufacturer with licensing partnerships (e.g., Gilead, BMS) and direct sales force; competes with Searle and IBL Operations in the same therapeutic areas.

TypeBroad incumbent
Description

One of Pakistan's largest pharmaceutical manufacturers and marketers, overlapping with IBL/Searle in branded pharma distribution and marketing across therapeutic categories.

TypeDirect peer
Description

Pakistan-listed holding company with stakes in fertilizers, foods, energy, and telecommunications; analogous to IBL as a diversified domestic holding entity.

TypeEmerging player
Description

Pakistan-origin enterprise software and IT services provider serving global financial and leasing clients; overlaps with IBL Unisys in the enterprise IT segment.

TypeDirect peer
Description

Pakistani diversified group covering cement, automotive, energy, and consumer businesses with multi-subsidiary structure and family ownership; comparable in conglomerate breadth and domestic focus.

TypeBroad incumbent
Description

Pakistani pharmaceutical manufacturer with international licensing partnerships and a national distribution network, comparable to Searle's branded pharma model.

TypeOthers
Description

BAT subsidiary in Pakistan with historical ties to IBL's 1887 origins as W.D. & H.O. Wills distributors; relevant for understanding IBL's legacy distribution heritage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

International Brands

Diversified Business Conglomerateiblgrp.com

International Brands (Private) Limited-IBL is a Pakistani diversified conglomerate operating subsidiaries across pharmaceutical manufacturing and distribution (Searle, IBL Operations), healthcare nutrition licensing (Mead Johnson, Nestle Health Science), consumer goods distribution (United Brands), enterprise IT integration (IBL Unisys), home furnishings retail (Habitt), and LED/solar solutions (Future Technologies), serving enterprise and consumer customers across Pakistan.

What International Brands does

International Brands (Private) Limited-IBL is a Pakistani diversified business house headquartered in Karachi, operating through a portfolio of subsidiary companies spanning pharmaceutical manufacturing and distribution, consumer goods distribution, enterprise IT systems integration, home furnishings retail, and LED/solar energy solutions. The group traces its origins to 1887 as a distribution house for W.D. & H.O. Wills cigarettes across the Indian subcontinent, was reorganized as UDL – United Distributors after the 1947 partition, and was formally constituted as IBL in 1991 to extend distribution reach and diversify into manufacturing and marketing. Its core pharmaceutical franchise is built around The Searle Company Limited (acquired in 1993 from G.D. Searle), one of the largest pharma companies in Pakistan by therapeutic breadth, and IBL Operations, which serves as sole representative for sales and distribution. The group's revenue model is multi-stream: transaction-fee pharmaceutical distribution (Searle), consumer goods distribution and brand-building services (United Brands Limited, publicly listed on Pakistan Stock Exchange), licensing/royalty arrangements for healthcare nutrition and medical disposables (Mead Johnson, Nestle Health Science, Terumo, Meditech, Mepaco), professional services for enterprise IT integration (IBL Unisys with Cisco, Dell, EMC, Microsoft, Unisys, VMware), hardware/retail through Habitt, and LED lighting and solar renewable solutions via Future Technologies.

The company serves enterprise and institutional customers across Pakistan, including pharmaceutical manufacturers, multinational consumer brands, banks, telecom operators, government agencies, energy-sector enterprises, and educational institutions, with downstream reach to Pakistani consumers through Habitt retail and Searle products. Its go-to-market relies on field sales teams, exclusive distribution rights, enterprise IT systems integration, and licensing/royalty structures financed through capital deployed in acquisitions and subsidiary build-outs. The 1,001–5,000 employee base is distributed across the registered offices of IBL Operations and United Brands (NIC Building, Abbasi Shaheed Road, Karachi) and the main headquarters at One IBL Center, Tipu Sultan Road. Limited public transparency exists around revenue, pricing, and ownership beyond the founding Abdulla family, and the group has faced regulatory scrutiny from the Competition Commission of Pakistan over an anti-competitive non-compete agreement (Rs 40 million cumulative penalty upheld by the Competition Appellate Tribunal).

International Brands firmographics

Firmographics
Name
International Brands
Legal name
International Brands (Private) Limited
Website
https://iblgrp.com
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
International Brands (Private) Limited-IBL is a Pakistani diversified conglomerate operating subsidiaries across pharmaceutical manufacturing and distribution (Searle, IBL Operations), healthcare nutrition licensing (Mead Johnson, Nestle Health Science), consumer goods distribution (United Brands), enterprise IT integration (IBL Unisys), home furnishings retail (Habitt), and LED/solar solutions (Future Technologies), serving enterprise and consumer customers across Pakistan.
Ownership category
akta.pro rank

Where International Brands is headquartered

Location

Headquarters

HQ city
Karachi
HQ country
Pakistan
HQ region
Asia

Offices3 records

Markets served

International Brands business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Pharmaceutical Distribution and Marketing: IBL Operations serves as sole representative of The Searle Company Limited, managing marketing, promotion, and distribution of pharmaceutical products through a network of refined experts.
  2. Consumer Goods Trading and Distribution: United Brands Limited trades and distributes consumer goods and allied products, providing brand building services including brand communications, activations, channel development, trade marketing, modern trade activations, merchandising, in-store promotions, pricing and market intelligence.
  3. Healthcare Products Marketing: IBL Healthcare markets products under licensing agreements with international companies including Mead Johnson Nutrition, Nestle Health Science, Terumo, Meditech and Mepaco in infant formula, adult nutrition and medical disposable products.
  4. Technology Solutions Integration: IBL Unisys provides technology implementation and support services as a system integrator for enterprise clients in banking, telecom, government, and energy sectors.
  5. Retail and Home Furnishings: Habitt operates as a one-stop home store solution for Pakistani consumers, offering superior quality products and value for money.
  6. LED Lighting and Renewable Energy Solutions: Future Technologies markets LED lighting solutions, Building Management Systems and Solar Renewables with comprehensive product warranties and on-site support.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels2 records

International Brands product offering

Product offering

Core offering

International Brands (Private) Limited is a diversified business house that manufactures, markets, distributes, and sells pharmaceutical, consumer goods, healthcare nutrition, enterprise IT, home furnishings, and LED/renewable energy products through multiple subsidiaries operating primarily in Pakistan. Its core operations include pharmaceutical manufacturing and exclusive distribution (Searle, IBL Operations), consumer goods trading for international brands (United Brands Limited), enterprise IT system integration with global vendors (IBL Unisys), home retail (Habitt), and renewable energy solutions (Future Technologies).

Product overview

International Brands (Private) Limited (IBL) is a diversified business house operating as a platform of multiple subsidiary and affiliated companies. The portfolio includes: SEARLE (pharmaceutical manufacturing and marketing), IBL Operations (pharmaceutical and nutritional product distribution), IBL HealthCare (healthcare nutritional products and medical disposables marketing), United Brands Limited (consumer goods trading and distribution), IBL Unisys (technology system integration), Habitt (home furnishings retail), and Future Technologies (LED lighting and renewable energy solutions). These entities operate independently under the IBL Group umbrella, providing distribution, manufacturing, marketing, retail, and technology services primarily in Pakistan.

Differentiator

Problem solved

Functional benefit

Brands

  • Searle: Pharmaceutical company manufacturing and marketing pharmaceutical products including allergy/cough/cold, analgesics, antibiotics, cardiovascular, gastrointestinal, and other therapeutic categories.
  • IBL Operations
  • IBL HealthCare
  • United Brands Limited
  • IBL Unisys
  • Habitt
  • Future Technologies

Products and services

  • The Searle Company Limited (Searle) Pharmaceutical company engaged in manufacturing and marketing of pharmaceutical products across therapeutic categories including allergy/cough/cold, analgesics, antibiotics, cardiovascular, gastrointestinal, neurological, and nutritional products in Pakistan.
  • IBL Operations (Private) Limited

Quantifiable outcome

  • Serving over 200,000 students through The Citizen Foundation
  • +1 more outcomes

Companies that use International Brands

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles5 records

International Brands technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

International Brands partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core.

  • The Searle Company LimitedcoreStrategic or Co-development PartnerIBL Operations is a subsidiary and sole representative of The Searle Company Limited, handling all aspects from product launch, development and sales growth to marketing, distribution and awareness creation of pharmaceutical products.
  • CiscocoreTechnology or IntegrationIBL Unisys operates as a technology system integrator in partnership with Cisco for enterprise IT solutions.
  • DellcoreTechnology or IntegrationIBL Unisys provides enterprise IT solutions in partnership with Dell.
  • EMCcoreTechnology or IntegrationIBL Unisys provides enterprise IT solutions in partnership with EMC.
  • MicrosoftcoreTechnology or IntegrationIBL Unisys provides enterprise IT solutions in partnership with Microsoft.
  • VMwarecoreTechnology or IntegrationIBL Unisys provides enterprise IT solutions in partnership with VMware.
  • UnisyscoreTechnology or IntegrationIBL Unisys operates as a technology system integrator in partnership with Unisys for enterprise IT solutions.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

International Brands competitors and assessment

Company assessment

Emerging players

  • Systems Limited: Pakistan-founded IT services and system integrator with enterprise and digital transformation offerings, comparable to IBL Unisys's enterprise IT integration business.
  • NetSol Technologies: Pakistan-origin enterprise software and IT services provider serving global financial and leasing clients; overlaps with IBL Unisys in the enterprise IT segment.

Direct peers

  • Nishat Group: Pakistani family-owned conglomerate active in textiles, cement, banking, and consumer goods; comparable diversification pattern and domestic-market orientation.
  • Engro Corporation: Pakistani diversified conglomerate with operations across fertilizers, foods, energy, and trading; comparable to IBL as a holding-company structure with multiple listed subsidiaries serving Pakistan's domestic market.
  • Dawood Hercules Corporation: Pakistan-listed holding company with stakes in fertilizers, foods, energy, and telecommunications; analogous to IBL as a diversified domestic holding entity.
  • Lucky Cement (Yunus Brothers Group): Pakistani diversified group covering cement, automotive, energy, and consumer businesses with multi-subsidiary structure and family ownership; comparable in conglomerate breadth and domestic focus.

Broad incumbents

  • Ferozsons Laboratories: Listed Pakistani pharmaceutical manufacturer with licensing partnerships (e.g., Gilead, BMS) and direct sales force; competes with Searle and IBL Operations in the same therapeutic areas.
  • Getz Pharma: One of Pakistan's largest pharmaceutical manufacturers and marketers, overlapping with IBL/Searle in branded pharma distribution and marketing across therapeutic categories.
  • Highnoon Laboratories: Pakistani pharmaceutical manufacturer with international licensing partnerships and a national distribution network, comparable to Searle's branded pharma model.

Others

  • Pakistan Tobacco Company: BAT subsidiary in Pakistan with historical ties to IBL's 1887 origins as W.D. & H.O. Wills distributors; relevant for understanding IBL's legacy distribution heritage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

International Brands social profiles

Digital presence

International Brands financial estimates

Financial estimate

Revenue estimate

Valuation estimate

International Brands leadership team

Management profile

Number of profiles

Profiles6 records

International Brands subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

International Brands funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

International Brands M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Brands

What does International Brands do?

International Brands (Private) Limited is a diversified business house that manufactures, markets, distributes, and sells pharmaceutical, consumer goods, healthcare nutrition, enterprise IT, home furnishings, and LED/renewable energy products through multiple subsidiaries operating primarily in Pakistan. Its core operations include pharmaceutical manufacturing and exclusive distribution (Searle, IBL Operations), consumer goods trading for international brands (United Brands Limited), enterprise IT system integration with global vendors (IBL Unisys), home retail (Habitt), and renewable energy solutions (Future Technologies).

Is International Brands a public or private company?

International Brands is a private company. It is classified as family owned and is currently operating.

When was International Brands founded?

International Brands was founded in 1991. It employs 1,001 to 5,000 people.

Where is International Brands based?

International Brands is headquartered in Karachi, Pakistan, in the Asia region.

How does International Brands make money?

Six revenue lines are on record. Pharmaceutical Distribution and Marketing is the primary driver. The others are consumer Goods Trading and Distribution, healthcare Products Marketing, technology Solutions Integration, retail and Home Furnishings and LED Lighting and Renewable Energy Solutions.

Who are International Brands's main competitors?

Emerging players on record are Systems Limited and NetSol Technologies. Direct peers are Nishat Group, Engro Corporation, Dawood Hercules Corporation and Lucky Cement (Yunus Brothers Group). Broad incumbents are Ferozsons Laboratories, Getz Pharma and Highnoon Laboratories. Pakistan Tobacco Company is listed as an others.

Does International Brands have an API?

No public API is recorded for International Brands.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechJuiceCCP Fines Two Firms Rs 40 Million for Anti-Competitive AgreementThe Competition Commission of Pakistan (CCP) has recovered Rs. 40 million in penalties from United Distributors Pakistan Limited (UDPL) and International Brands (Private) Limited (IBL) after both companies entered into an anti-competitive non-compete agreement that violated Section 4 of the Competition Act, 2010. Under the agreement, UDPL stopped distributing human pharmaceutical products in Pakistan for three years in exchange for Rs. 1.131 billion from IBL, effectively removing UDPL as a competitor from the pharmaceutical distribution market. The CCP's recovery is part of a broader enforcement push that saw Rs. 932.56 million in penalties recovered during 2025, signaling developing enforcement capacity in Pakistan's competition framework.TechJuiceTribunal Upholds CCP Penalty Against Two Medicine DistributorsThe Competition Appellate Tribunal in Pakistan upheld a Rs. 40 million cumulative penalty against United Distributors Pakistan Limited and International Brands for violating Section 4 of the Competition Act, 2010 through an illegal anti-competitive non-compete agreement. The case centered on a Rs. 1.131 billion arrangement where IBL paid UDPL to exit the pharmaceutical distribution market for three years, which regulators classified as an illegal market-sharing arrangement. Both companies failed to obtain prior regulatory exemption from the Competition Commission of Pakistan and only applied for approval after receiving show-cause notices, leading the Tribunal to view their inaction as implicit acceptance of guilt.Business Recorder‘Violation’ of Sec 4: CAT upholds Rs40m CCP penalty on UDPL and IBLThe Competition Appellate Tribunal (CAT) upheld a cumulative penalty of PKR 40 million imposed by the Competition Commission of Pakistan (CCP) on United Distributors Pakistan Limited (UDPL) and International Brands (Private) Limited (IBL) for violating Section 4 of the Competition Act, 2010 through an anti-competitive non-compete agreement. UDPL agreed not to distribute human pharmaceutical products in Pakistan for three years in exchange for PKR 1.131 billion from IBL, effectively eliminating UDPL as a competitor and restricting market competition. Both companies failed to obtain prior regulatory exemption and did not pursue further legal remedies after their exemption application was rejected, leading the Tribunal to affirm the penalty of PKR 20 million on each company as justified.Business RecorderCAT upholds Rs40mn penalty on UDPL, IBL over anti-competitive agreementThe Competition Appellate Tribunal (CAT) upheld a Rs40 million cumulative penalty imposed by the Competition Commission of Pakistan (CCP) on United Distributors Pakistan Limited and International Brands (Private) Limited for violating Section 4 of the Competition Act, 2010 through an anti-competitive non-compete agreement. The agreement prevented UDPL from distributing human pharmaceutical products in Pakistan for three years in exchange for a payment of Rs1.131 billion from IBL, which the CCP found effectively eliminated UDPL as a competitor and restricted competition in the relevant market. CAT affirmed that both companies failed to obtain prior regulatory exemption and did not pursue further legal remedies after their exemption application was rejected, implying acceptance of the contravention.PakobserverTribunal rejects Kingdom Valley appeal, allows CCP to collect Rs150 million penaltyThe Competition Appellate Tribunal rejected Kingdom Valley Pvt Ltd's appeal, allowing the Competition Commission of Pakistan to enforce a Rs150 million penalty for deceptive marketing practices including falsely advertising a housing project as being in Islamabad when it is located in Rawalpindi. The tribunal directed Kingdom Valley to deposit Rs75 million (50% of the penalty) and submit post-dated cheques for the remainder, while in a separate case it ordered United Distributors and International Brands Limited to provide a Rs20 million bank guarantee for an illegal non-compete agreement that restricted competition in the pharmaceutical distribution market. The CCP found that International Brands Limited had paid over Rs1.13 billion to United Distributors to stay out of the human pharmaceutical distribution market for three years, violating Section 4 of the Competition Act 2010.